Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,660 | 1,230 | 67.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,600 | 3 | 16.5% |
| Consulting Fee | $2,200 | 4 | 10.1% |
| Travel and Lodging | $1,177 | 7 | 5.4% |
| Education | $165.13 | 40 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,086 | 103 | $0 (2022) |
| Lilly USA, LLC | $2,639 | 48 | $0 (2022) |
| PFIZER INC. | $2,001 | 229 | $0 (2022) |
| Novo Nordisk Inc | $1,110 | 100 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,049 | 56 | $0 (2022) |
| Allergan, Inc. | $882.60 | 131 | $0 (2021) |
| GlaxoSmithKline, LLC. | $801.31 | 60 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $738.06 | 52 | $0 (2022) |
| Amgen Inc. | $737.06 | 47 | $0 (2022) |
| Amarin Pharma Inc. | $673.20 | 59 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,211 | 73 | Novo Nordisk Inc ($206.19) |
| 2021 | $2,512 | 190 | AbbVie Inc. ($321.85) |
| 2020 | $2,447 | 192 | Allergan, Inc. ($304.31) |
| 2019 | $2,539 | 230 | PFIZER INC. ($365.76) |
| 2018 | $2,583 | 233 | PFIZER INC. ($493.93) |
| 2017 | $10,511 | 366 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,220) |
All Payment Transactions
1,284 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: VACCINES | ||||||
| 06/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 05/31/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: Diabetes | ||||||
| 05/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: DIABETES | ||||||
| 05/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Diabetes | ||||||
| 05/23/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Inflammation | ||||||
| 05/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Diabetes | ||||||
| 05/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $89.88 | General |
| Category: Cardiology | ||||||
| 05/12/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $89.88 | General |
| Category: Cardiology | ||||||
| 05/11/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: VACCINES | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $63.45 | General |
| Category: Respiratory | ||||||
| 05/05/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: PRIMARY CARE | ||||||
| 05/05/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular | ||||||
| 05/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Diabetes | ||||||
| 05/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.20 | General |
| Category: Diabetes | ||||||
| 05/02/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,031 | 3,497 | $867,196 | $278,241 |
| 2022 | 11 | 787 | 2,266 | $365,421 | $136,744 |
| 2021 | 10 | 1,259 | 3,958 | $570,699 | $236,112 |
| 2020 | 11 | 1,284 | 3,636 | $478,676 | $194,363 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 257 | 1,795 | $344,051 | $110,444 | 32.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 253 | 1,080 | $311,886 | $100,116 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 248 | 299 | $126,136 | $40,386 | 32.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 230 | 270 | $74,670 | $23,925 | 32.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 16 | $5,104 | $1,625 | 31.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 24 | $2,856 | $935.28 | 32.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $2,493 | $810.03 | 32.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 151 | 1,307 | $194,312 | $72,624 | 37.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 119 | 133 | $55,319 | $20,610 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 173 | 278 | $35,728 | $13,410 | 37.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 162 | $34,270 | $12,915 | 37.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 111 | 118 | $17,362 | $6,573 | 37.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 67 | 123 | $9,747 | $3,729 | 38.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 26 | 28 | $7,084 | $2,259 | 31.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 44 | $3,916 | $1,603 | 40.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,528 | $1,602 | 45.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 16 | 34 | $2,108 | $845.96 | 40.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 24 | $2,047 | $572.57 | 28.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 237 | 1,928 | $273,776 | $108,576 | 39.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 248 | 680 | $85,020 | $43,056 | 50.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 214 | 247 | $98,800 | $38,592 | 39.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 194 | 622 | $48,516 | $18,502 | 38.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 194 | 212 | $30,740 | $11,852 | 38.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 75 | $12,075 | $6,077 | 50.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 20 | 23 | $5,129 | $3,397 | 66.2% |
About Dr. Timothy Saxe, M.D
Dr. Timothy Saxe, M.D is a Internal Medicine healthcare provider based in Huntington, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174520282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Saxe, M.D has received a total of $21,802 in payments from pharmaceutical and medical device companies, with $1,211 received in 2022. These payments were reported across 1,284 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($14,660).
As a Medicare-enrolled provider, Saxe has provided services to 4,361 Medicare beneficiaries, totaling 13,357 services with total Medicare billing of $845,460. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Huntington, WV
- Active Since 07/05/2005
- Last Updated 03/22/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174520282
Products in Payments
- JARDIANCE (Drug) $7,743
- FARXIGA (Drug) $717.62
- Vascepa (Drug) $673.20
- XARELTO (Drug) $646.73
- Ozempic (Drug) $592.30
- VRAYLAR (Drug) $591.48
- TRELEGY ELLIPTA (Drug) $509.50
- NUEDEXTA (Drug) $508.93
- Repatha (Biological) $436.41
- PREVNAR - 13 (Biological) $427.15
- JANUVIA (Drug) $409.25
- TRULICITY (Drug) $381.04
- XIFAXAN (Drug) $363.37
- Victoza (Drug) $327.72
- CHANTIX (Drug) $320.46
- PREVNAR 13 (Biological) $318.41
- STIOLTO RESPIMAT (Drug) $310.77
- UBRELVY (Drug) $294.75
- LYRICA (Drug) $242.21
- ELIQUIS (Drug) $201.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntington
Aamir Cheema, M.d, M.D
Internal Medicine — Payments: $207,509
Kofi Osei, Md, MD
Internal Medicine — Payments: $78,202
Wesam Frandah, Md, MD
Internal Medicine — Payments: $28,363
Murad Kheetan, Md, MD
Internal Medicine — Payments: $25,358
Rameez Sayyed, Md, MD
Internal Medicine — Payments: $24,444
David Patick, Md, MD
Internal Medicine — Payments: $23,768